Financials

News Ideas Technicals Forecast

XERS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Xeris Biopharma Holdings, Inc.

Total assets of XERS for Q4 23 is 340.80 M USD, 3.97% more than the previous Q3 23. And total liabilities increased by 7.30% in Q4 23 to 347.58 M USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—